Cefivitril

This classification denotes a cephalosporin antibiotic with the molecular formula C15H15N7O4S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 776E09GMHQ, chemically known as (6r,7r)-7-(2-(((z)-2-cyanovinyl)thio)acetamido)-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid. but more generally known as cefivitril, which bears US NIH Compound Identifier 6443795. European Medicines Agency schedules Cefivitril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07394MIG. The term CEFIVITRIL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 39, No. 5, 1985, List 25). CEFIVITRIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule cefivitril under HS 29419000 and SITC 54139. As of Q4 2014, CEFIVITRIL remains US FDA's Preferred Term for this commodity. Cefivitril bears US NLM identifiers UMLS ID C2699140 and NCI Concept Code C76167. SMILES: S1C2N(C(=O)C2NC(=O)CS/C=C\C#N)C(=C(C1)CSC1N(NNN1)C)C(=O)O.